| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/25/2004 | EP1448150A2 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 08/25/2004 | EP1343764B1 Urea and urethane derivatives as integrin inhibitors |
| 08/25/2004 | EP1228235B1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/25/2004 | EP1212067A4 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 08/25/2004 | EP1200457B1 Cysteine protease inhibitors |
| 08/25/2004 | EP1149069B1 Phenylglycine derivatives |
| 08/25/2004 | EP1087963B1 Inhibitors of glycogen synthase kinase 3 |
| 08/25/2004 | EP1086080B1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/25/2004 | EP1083903B1 Bridged indenopyrrolocarbazoles |
| 08/25/2004 | EP1082138B1 Texaphyrin conjugates and uses thereof |
| 08/25/2004 | EP1064018B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 08/25/2004 | EP1025094B1 Substituted indan derivatives |
| 08/25/2004 | EP0983072B1 Use of fructan for the manufacture of a medicament for the prevention and treatment of colon cancer |
| 08/25/2004 | EP0893449B1 Antitumor substance extracted from hen-of-the-woods |
| 08/25/2004 | EP0881906B1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/25/2004 | EP0873424B1 Metastasis inducing dna's |
| 08/25/2004 | EP0839054B1 Tissue or cell-specific herpes simplex virus replication |
| 08/25/2004 | EP0724632B1 Stem cell proliferation factor |
| 08/25/2004 | CN1524085A Oligose ,sulfating product and oligose cluster and its uses |
| 08/25/2004 | CN1524082A Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl idase inhibitors for the treatment or prevention of diabetes |
| 08/25/2004 | CN1524081A Pyrimidine derivatives for inhibition of cell proliferation |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 08/25/2004 | CN1523997A Stabilized interleukin 2 |
| 08/25/2004 | CN1523992A Compositions and methods for treating amyloidosis |
| 08/25/2004 | CN1523991A Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1523106A Method for preparing bacteria super antigen utilizing gene engineering means |
| 08/25/2004 | CN1523041A Bulgaria inquinans polysaccharide, method for preparing the same and pharmaceutical composition using the compound as active component |
| 08/25/2004 | CN1523040A Fusion protein of human thymosin alpha1 and human composite interferon and preparation thereof |
| 08/25/2004 | CN1523039A Monoclonal antibody GDK-1 of anti-cell membrane glucoprotein KD-43 and its iodide DGDK-1 and application |
| 08/25/2004 | CN1523035A Medication containing 1,6-methylene-[10]-annulene-furan and steroid |
| 08/25/2004 | CN1523023A Taxone bromated analog with anticancer activity and preparation method thereof |
| 08/25/2004 | CN1523018A Heteropolyacid 5-fluorouracil antineoplastic and method for synthesizing the same |
| 08/25/2004 | CN1522994A Use of plant extract of anoectochilus formosanus and fraction originating from the same as galenicals or dietary supplement for chemical defense or treatment of human malignant lesion |
| 08/25/2004 | CN1522762A Adjuvant free GRH antibody polypeptide vaccine and its preparation method |
| 08/25/2004 | CN1522759A Interferon and synergist combined pharmaceutical |
| 08/25/2004 | CN1522751A Leukemia therapeutic pharmaceuticals |
| 08/25/2004 | CN1522748A Anti-cancer liquid drug |
| 08/25/2004 | CN1522718A Active dismutase and proteolytic enzyme extraction technology from whole scorpion, and its application |
| 08/25/2004 | CN1522710A Use of CoCl#-[2] in preparation of drug for treating leukemia |
| 08/25/2004 | CN1522708A Use of 2,3-0 desulphurizing heparin in preparation of drug for prevention and cure of tumour transfer |
| 08/25/2004 | CN1163505C Anticancer polypeptide |
| 08/25/2004 | CN1163492C 'Delta' 12,13-iso-taxol analogs, antineoplastic use and pharmaceutical composition containing them |
| 08/25/2004 | CN1163480C Styryl sulfone anticancer agent |
| 08/25/2004 | CN1163477C Substituted beta-alanine |
| 08/25/2004 | CN1163475C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivative and use as MEK inhibitor thereof |
| 08/25/2004 | CN1163466C Substituted oxobutyric acid derivative as matrix metalloprotease inhibitor |
| 08/25/2004 | CN1163273C Antimatrix metalloprotease monovalent antibody Fab' medicine conjugate and its tumor-resisting action |
| 08/25/2004 | CN1163252C Tumour assistantly therapeutic drug and its preparing process |
| 08/25/2004 | CN1163237C Use of arsenic hexoxide (AS4O6)in preparation of Anti-cancer drug |
| 08/25/2004 | CN1163225C Pharmaceutical composition containing amino-acid adduct |
| 08/24/2004 | US6781002 Antioxidant from natural source |
| 08/24/2004 | US6780996 Process for the preparation of 7-substituted-3 quinolinecarbonitriles |
| 08/24/2004 | US6780995 Activated iododerivatives for the treatment of cancer and aids |
| 08/24/2004 | US6780994 Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 08/24/2004 | US6780972 Reacting an acid addition salt of a basic starting peptide in the presence of a diluent in a mixed bed ion exchanger; forming a free peptide; and then forming the desired acid addition salt of the peptide |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780884 Derivating of tryptamine and analogous compounds and pharmaceutical formulations containing them |
| 08/24/2004 | US6780879 As antitumor agent |
| 08/24/2004 | US6780873 Urea substituted imidazoquinolines |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780867 Thienopyrimidines |
| 08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
| 08/24/2004 | US6780642 Association of SIM2 with cancer |
| 08/24/2004 | US6780640 Human carboxypeptidases and polynucleotides encoding the same |
| 08/24/2004 | US6780626 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/24/2004 | US6780441 Composition of eleven herbals for treating cancer |
| 08/24/2004 | US6780324 Preparation of sterile stabilized nanodispersions |
| 08/24/2004 | CA2293711C Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
| 08/24/2004 | CA2258013C Substituted benzylidene indenyl formamides, acetamides and propionamides |
| 08/19/2004 | WO2004070050A2 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | WO2004070012A2 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | WO2004069999A2 Screening method |
| 08/19/2004 | WO2004069992A2 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | WO2004069991A2 Oligomeric compounds for the modulation of survivin expression |
| 08/19/2004 | WO2004069898A1 Polymer guanidine derivatives as a cytostatic medicament |
| 08/19/2004 | WO2004069876A2 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | WO2004069871A1 Growth factor complexes and modulation of cell migration and growth |
| 08/19/2004 | WO2004069869A1 Apoptosis-inducing gene and utilization of the same |
| 08/19/2004 | WO2004069856A1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 08/19/2004 | WO2004069855A1 Novel glycosyl transferase with consideration of activity expression mechanism and method of producing the same |
| 08/19/2004 | WO2004069847A1 Nucleoside analogues with apoptosis-inducing characteristics for treating diseases caused by rapidly proliferating cells |
| 08/19/2004 | WO2004069844A1 Novel tricyclic oxazepine derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 08/19/2004 | WO2004069843A1 Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same |
| 08/19/2004 | WO2004069827A1 Quinoline derivatives and use thereof as antitumor agents |
| 08/19/2004 | WO2004069823A1 Inhibitors of histone deacetylase |
| 08/19/2004 | WO2004069820A1 Coumarin derivatives having an affinity for oestrogen receptors, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | WO2004069274A2 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 08/19/2004 | WO2004069250A1 3-cyano-quinoline derivatives as non-receptor tyrosine kinase inhibitors |
| 08/19/2004 | WO2004069249A1 3-cyano-quinoline derivatives as non-receptor tyrosine kinase inhibitors |
| 08/19/2004 | WO2004069243A1 Breast cancer resistance protein (bcrp) inhibitor |
| 08/19/2004 | WO2004069233A1 Breast cancer-resistant protein inhibitor |
| 08/19/2004 | WO2004069133A2 N-monoacylated o-phenylenediamines as anti -cancer agents |
| 08/19/2004 | WO2004068931A2 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | WO2004061408A3 Use of a non-specific inhibitor of the 5ht2b receptor for the treatment of prostate cancer |